Xin Yan

Dr. Xin Yan


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
JJJia Jia
Jia Jia
XLXiang Li
Xiang Li
XRXueyang Ren
Xueyang Ren
XLXiaoyun Liu
Xiaoyun Liu
YWYu Wang
Yu Wang
GSGaimei She
Gaimei She

11 December 2025 in Progress in Neurobiology
Verified
Journal Article
Closed access
CZChuxin Zhang
Chuxin Zhang
JCJialin Cheng
Jialin Cheng
XYXin Yan
Xin Yan
YZYuxiao Zheng
Yuxiao Zheng
XLXin Lan
Xin Lan
XWXueqian Wang
Xueqian Wang

15 May 2026 in Biosensors
Verified
Journal Article
Open access
PDF file
NLNan Li
Nan Li
XLXing-Liang Liu
Xing-Liang Liu
BSBoyuan Shi
Boyuan Shi
CSChunhui Song
Chunhui Song
TZTeng Zhang
Teng Zhang
JMJun Ma
Jun Ma
The abuse of γ-hydroxybutyric acid (GHB) and its precursors, γ-butyrolactone (GBL) and 1,4-butanediol (1,4-BD), has increased in recent years, with these substances frequently being illicitly added to beverages. GHB is colorless and odorless and exhibits anesthetic and hypnotic psychoactive effects, which are often exploited in drug-facilitated sexual assault, posing a significant public safety concern. Chromatography–tandem mass spectrometry is a conventional analytical approach for narcotic drug determination due to its high sensitivity and accuracy; however, its large instrumentation footprint and high operational cost limit its suitability for on-site rapid screening. In response to the growing demand for field-deployable analytical tools, rapid detection technologies for GHB have progressively evolved. This review summarizes and compares the advantages and limitations of current rapid detection methods for GHB and discusses their potential future developmental trends, with the aim of providing a reference for researchers and relevant authorities.

24 July 2026 in Biosensors
Verified
Journal Article
Open access
PDF file
XYXin Yan
Xin Yan
LJLiwei Jiang
Liwei Jiang
XZXiaolong Zhang
Xiaolong Zhang
YZYizhe Zhao
Yizhe Zhao
ZWZixin Wan
Zixin Wan
XLXing-Liang Liu
Xing-Liang Liu
Etomidate is an ultrashort-acting imidazole-derived intravenous anesthetic. The non-medical abuse of etomidate as a new psychoactive substance has emerged as a critical public health challenge globally, particularly among adolescents, necessitating sensitive, rapid detection methods for forensic analysis. This study developed a quantum dot-based immunochromatographic test strip and a corresponding rapid detection method for the sensitive detection of etomidate acid in urine. CdSe/ZnS fluorescent quantum dot microspheres were used as labeling probes combined with specific monoclonal antibodies, and the detection protocol utilized a portable fluorescence reader. The method’s validation demonstrated a linear range of 10–2000 ng/mL (y = −0.231lnx + 0.5241, r = −0.991), with intra-batch and inter-batch coefficients of variation below 12%. The spike recovery rates ranged from 88.24% to 95.69%. Cross-reactivity testing against 12 common drugs and structural analogs showed no interference. The detection limit of 10 ng/mL represents a substantial improvement over conventional colloidal gold strips and approaches LC-MS/MS sensitivity. Assays of real urine specimens confirmed that the immunochromatographic test strip and detection method possess favorable accuracy and reliability. This fluorescent quantum dot-based immunochromatographic assay provides rapid, quantitative, and highly specific etomidate screening suitable for on-site forensic applications, effectively bridging front-end rapid testing with confirmatory laboratory analysis.